Provectus reports oral PV-10 shows anti-tumor activity in bladder cancer study May 18, 2026 08:02AM
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics Jan 14, 2025 08:45AM
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections Dec 10, 2024 07:30AM
Provectus Biopharma (PVCT) Reports Q3 EPS of $0.00 Nov 14, 2024 04:42PM